TSE:EDT Spectral Medical (EDT) Stock Forecast, Price & News C$0.34 +0.01 (+3.03%) (As of 09/29/2023 ET) Add Compare Share Share Today's RangeC$0.34▼C$0.3550-Day RangeC$0.31▼C$0.4252-Week RangeC$0.23▼C$0.47Volume26,500 shsAverage Volume52,400 shsMarket CapitalizationC$94.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsHeadlinesSocial MediaProfileChartCompetitorsEarningsHeadlinesSocial Media About Spectral Medical (TSE:EDT) StockSpectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.Read More EDT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EDT Stock News HeadlinesSeptember 13, 2023 | stockhouse.comCORRECTION - Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note FinancingSeptember 8, 2023 | finance.yahoo.comSpectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Septic ShockOctober 1, 2023 | Porter and Company (Ad)Public Service Announcement: New National Emergency IncomingAmericans urged to share this new documentary with their friends and family before this looming event triggers a new national crisis… September 7, 2023 | finance.yahoo.comSpectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note FinancingAugust 25, 2023 | seekingalpha.comEDTXF Spectral Medical Inc.August 25, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc up on Thursday (EDT)August 23, 2023 | theglobeandmail.comSpectral Medical: Top 10 Undervalued Healthcare Sector Stocks on TSX (EDT)August 22, 2023 | finance.yahoo.comSpectral Medical Inc. Announces Upsizing of Previously Announced Bought Deal Convertible Note Financing to C$5.5MOctober 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.August 21, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc up on Monday (EDT)August 16, 2023 | benzinga.comSpectral Medical Highlights New Episode of 'The Balancing Act' Airing on Lifetime TV Focused on Endotoxic ShockAugust 16, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc up on Wednesday (EDT)August 16, 2023 | finance.yahoo.comSpectral Medical Highlights New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic ShockAugust 10, 2023 | finance.yahoo.comSpectral Medical Announces Second Quarter Results and Provides Corporate UpdateAugust 7, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc flat on Friday (EDT)July 25, 2023 | finance.yahoo.comSpectral Medical Announces Tigris Clinical Trial UpdateJuly 23, 2023 | finance.yahoo.comInvestors in Spectral Medical (TSE:EDT) from a year ago are still down 43%, even after 11% gain this past weekJuly 19, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc up on Tuesday (EDT)June 20, 2023 | finance.yahoo.comSpectral Medical Provides Update on Continued Favorable Tigris Clinical Trial EnrollmentMay 24, 2023 | finance.yahoo.comSpectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment ActivitiesMay 24, 2023 | finance.yahoo.comSpectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment ActivitiesMay 12, 2023 | finanznachrichten.deSpectral Medical Inc.: Spectral Medical Announces First Quarter Results and Provides Corporate UpdateMay 9, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc flat on Tuesday (EDT)May 5, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc up on Friday (EDT)April 29, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc down on Friday (EDT)April 24, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc down on Monday (EDT)April 18, 2023 | finance.yahoo.comSpectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock PatientsSee More Headlines Receive EDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address EDT Company Calendar Last Earnings8/10/2023Today10/01/2023Next Earnings (Estimated)11/09/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolTSE:EDT Previous SymbolTSE:SDI CUSIPN/A CIKN/A Webwww.spectraldx.com Phone+1-416-6263233FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-9,230,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-973.97% Return on Assets-92.56% Debt Debt-to-Equity Ratio26.03 Current Ratio1.33 Quick Ratio0.45 Sales & Book Value Annual SalesC$1.74 million Price / Sales54.44 Cash FlowC$0.00 per share Price / Cash Flow82.50 Book ValueC($0.03) per share Price / Book-11.33Miscellaneous Outstanding Shares278,580,000Free FloatN/AMarket CapC$94.72 million OptionableNot Optionable Beta0.84 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Christopher SetoCEO & DirectorMr. Blair McInnisChief Financial OfficerDr. John A. Kellum M.D.Chief Medical OfficerKey CompetitorsScythian BiosciencesCVE:SCYB138267 (COM.TO)TSE:COMNovoheartCVE:NVHCipher PharmaceuticalsTSE:CPHCENTRIC HEALTHTSE:CHHView All Competitors EDT Stock - Frequently Asked Questions How have EDT shares performed in 2023? Spectral Medical's stock was trading at C$0.37 at the start of the year. Since then, EDT shares have decreased by 8.1% and is now trading at C$0.34. View the best growth stocks for 2023 here. When is Spectral Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our EDT earnings forecast. How were Spectral Medical's earnings last quarter? Spectral Medical Inc. (TSE:EDT) posted its quarterly earnings data on Thursday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.31 million for the quarter. What other stocks do shareholders of Spectral Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Spectral Medical investors own include Aurora Cannabis (ACB), CENTRIC HEALTH (CHH), Cequence Energy Ltd. (CQE.TO) (CQE), Cenovus Energy (CVE), Enbridge (ENB), Absolute Software Co. (ABT.TO) (ABT), Air Canada (AC), Alamos Gold (AGI), AltaGas (ALA) and Alimentation Couche-Tard (ATD.B). What is Spectral Medical's stock symbol? Spectral Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EDT." How do I buy shares of Spectral Medical? Shares of EDT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Spectral Medical's stock price today? One share of EDT stock can currently be purchased for approximately C$0.34. How much money does Spectral Medical make? Spectral Medical (TSE:EDT) has a market capitalization of C$94.72 million and generates C$1.74 million in revenue each year. The company earns C$-9,230,000.00 in net income (profit) each year or C($0.05) on an earnings per share basis. How can I contact Spectral Medical? Spectral Medical's mailing address is 135 the West Mall Unit 2, ETOBICOKE, ON M9C 1C2, Canada. The official website for the company is www.spectraldx.com. The company can be reached via phone at +1-416-6263233. This page (TSE:EDT) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.